105 filings
Page 2 of 6
8-K
lmil54p9j x4d0m
17 Oct 23
Talaris Therapeutics Announces Stockholder Approval of Merger with Tourmaline Bio
6:35pm
425
77x5e v061n1b
10 Oct 23
Business combination disclosure
4:32pm
8-K/A
pk1uqukk
10 Oct 23
Other Events
4:30pm
425
538b9vp b2al4
10 Oct 23
Business combination disclosure
12:00am
8-K
bwlpvpwcvo1o
6 Oct 23
Talaris Therapeutics Declares Special Dividend
5:30pm
425
1iwtvtma4c6p
6 Oct 23
Business combination disclosure
5:27pm
8-K
98b4klcuughahb
6 Oct 23
Other Events
5:26pm
425
8qpxo3mkixehqqti1
26 Sep 23
Business combination disclosure
8:24am
8-K
9hf8ne39edj n09hrl4m
26 Sep 23
Regulation FD Disclosure
8:21am
424B3
sguss36 mzkg12tq
15 Sep 23
Prospectus supplement
6:31am
EFFECT
jrp51 51nv0s
15 Sep 23
Notice of effectiveness
12:15am
SEC STAFF LETTER
zf57tryuooal8cpdzgh
14 Sep 23
SEC staff letter
12:00am
425
sxxt j5uzx1i6q25k4
13 Sep 23
Business combination disclosure
9:14am
8-K
qz2zpo061gz8p0l 69q
13 Sep 23
Regulation FD Disclosure
9:13am
CORRESP
dno7gui
13 Sep 23
Correspondence with SEC
12:00am
CORRESP
evzj9rt
11 Sep 23
Correspondence with SEC
12:00am
UPLOAD
dpiekm
6 Sep 23
Letter from SEC
12:00am
425
rjfbm85m7673m
28 Aug 23
Business combination disclosure
7:38am